X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (27688) 27688
Book Review (2915) 2915
Publication (1571) 1571
Newspaper Article (969) 969
Book Chapter (165) 165
Book / eBook (122) 122
Magazine Article (72) 72
Conference Proceeding (70) 70
Trade Publication Article (59) 59
Web Resource (41) 41
Dissertation (25) 25
Reference (6) 6
Data Set (4) 4
Newsletter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (24462) 24462
animals (17633) 17633
pancreas (11812) 11812
male (11637) 11637
humans (10466) 10466
rats (8910) 8910
pancreas - drug effects (8417) 8417
female (6241) 6241
pancreas - metabolism (5105) 5105
mice (4707) 4707
insulin (4271) 4271
diabetes (4210) 4210
insulin - metabolism (3188) 3188
endocrinology & metabolism (3110) 3110
glucose (2898) 2898
adult (2886) 2886
pancreas - pathology (2861) 2861
pancreas - enzymology (2784) 2784
abridged index medicus (2706) 2706
middle aged (2601) 2601
insulin secretion (2479) 2479
rodents (2413) 2413
surgery (2186) 2186
gastroenterology & hepatology (2166) 2166
diabetes mellitus (2144) 2144
cancer (2111) 2111
time factors (2072) 2072
physiology (2070) 2070
rats, wistar (2045) 2045
dose-response relationship, drug (1982) 1982
pancreatic cancer (1936) 1936
pancreas - secretion (1930) 1930
secretion (1919) 1919
biochemistry & molecular biology (1912) 1912
research (1902) 1902
in vitro techniques (1875) 1875
transplantation (1801) 1801
dogs (1760) 1760
proteins (1730) 1730
oncology (1725) 1725
pancreatitis (1692) 1692
expression (1690) 1690
islets of langerhans - drug effects (1688) 1688
pharmacology & pharmacy (1677) 1677
cell biology (1662) 1662
liver (1642) 1642
analysis (1632) 1632
apoptosis (1610) 1610
aged (1584) 1584
pancreas - cytology (1565) 1565
blood glucose - metabolism (1552) 1552
rats, sprague-dawley (1545) 1545
medicine (1531) 1531
islets of langerhans - metabolism (1528) 1528
rats, inbred strains (1468) 1468
glucose - pharmacology (1430) 1430
multidisciplinary sciences (1429) 1429
physiological aspects (1414) 1414
cells (1400) 1400
gene expression (1365) 1365
insulin - blood (1342) 1342
kinetics (1336) 1336
research article (1334) 1334
health aspects (1300) 1300
metabolism (1287) 1287
care and treatment (1229) 1229
medicine & public health (1208) 1208
pancreatic neoplasms - pathology (1173) 1173
cells, cultured (1153) 1153
immunology (1136) 1136
disease models, animal (1118) 1118
pancreas transplantation (1110) 1110
oxidative stress (1109) 1109
acute disease (1107) 1107
tumors (1100) 1100
studies (1087) 1087
inflammation (1067) 1067
science (1059) 1059
cholecystokinin - pharmacology (1045) 1045
liver - drug effects (1038) 1038
enzymes (1037) 1037
medicine, research & experimental (1007) 1007
treatment outcome (979) 979
activation (972) 972
insulin resistance (971) 971
rat (970) 970
pancreas - physiology (967) 967
hyperglycemia (965) 965
article (964) 964
calcium - metabolism (950) 950
patients (931) 931
signal transduction (931) 931
glucagon (930) 930
risk factors (919) 919
insulin-secreting cells - metabolism (909) 909
secretin - pharmacology (896) 896
amylases - metabolism (883) 883
immunohistochemistry (879) 879
cholecystokinin (878) 878
inhibition (876) 876
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (101) 101
Collection Dvlpm't (Acquisitions) - Closed Orders (6) 6
St. Michael's Hospital - Stacks (3) 3
Providence Healthcare - Reference (2) 2
Robarts - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Reference (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Credit Valley Hospital - Reference (1) 1
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - Reference (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Missing (1) 1
Online Resources - Online (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - Closed Orders (1) 1
Scarborough Hospital - General (1) 1
St Josephs Health Centre - General (1) 1
Sunnybrook Health Sciences Centre - Holland Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Toronto East General Hospital - Online (1) 1
Trillium Health Centre - Stacks (1) 1
UofT at Mississauga - Oversize (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (27441) 27441
Russian (436) 436
German (353) 353
French (306) 306
Japanese (157) 157
Italian (96) 96
Chinese (93) 93
Spanish (67) 67
Polish (58) 58
Ukrainian (24) 24
Hungarian (18) 18
Portuguese (16) 16
Czech (9) 9
Norwegian (6) 6
Bulgarian (5) 5
Korean (4) 4
Turkish (4) 4
Croatian (3) 3
Danish (3) 3
Romanian (3) 3
Dutch (2) 2
Persian (2) 2
Slovak (2) 2
Arabic (1) 1
Catalan (1) 1
Finnish (1) 1
Georgian (1) 1
Lithuanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gastroenterology, ISSN 0016-5085, 2014, Volume 146, Issue 7, pp. 1763 - 1774
Background & Aims The NACHT, LRR, and pyrin domain–containing protein 3 (NLRP3) inflammasome induces inflammation in response to organ injury, but little is... 
Gastroenterology and Hepatology | Innate Immune Response | Immune Regulation | Pancreas | Mouse Model | ACTIVATION | NLRP3 INFLAMMASOME | GPR81 | AGONISTS | GENE | TLR9 | MICE | HEPATOTOXICITY | GASTROENTEROLOGY & HEPATOLOGY | EXPRESSION | SEVERITY | Liver - pathology | Inflammasomes - metabolism | Receptors, G-Protein-Coupled - metabolism | NLR Family, Pyrin Domain-Containing 3 Protein | Humans | Male | NF-kappa B - metabolism | Monocytes - immunology | Lipopolysaccharides | Liver - immunology | Liver - drug effects | RNA Interference | Interleukin-1beta - metabolism | Toll-Like Receptors - drug effects | Anti-Inflammatory Agents - administration & dosage | Toll-Like Receptors - metabolism | Cytoprotection | Disease Models, Animal | Galactosamine | Chemical and Drug Induced Liver Injury - prevention & control | Anti-Inflammatory Agents - pharmacology | Down-Regulation | Liver - metabolism | Injections, Intraperitoneal | Pancreas - pathology | Pancreas - metabolism | Pancreas - immunology | Toll-Like Receptor 4 - metabolism | Chemical and Drug Induced Liver Injury - immunology | Monocytes - drug effects | Macrophages - metabolism | Signal Transduction - drug effects | Chemical and Drug Induced Liver Injury - metabolism | Sodium Lactate - pharmacology | beta-Arrestins | Mice | Receptors, G-Protein-Coupled - genetics | RNA, Small Interfering - metabolism | Monocytes - metabolism | Pancreatitis - prevention & control | Arrestins - metabolism | Dose-Response Relationship, Drug | Pancreatitis - genetics | Transfection | Inflammasomes - drug effects | Sodium Lactate - administration & dosage | Pancreatitis - immunology | Chemical and Drug Induced Liver Injury - pathology | Chemical and Drug Induced Liver Injury - etiology | Macrophages - immunology | Cell Line | Immunity, Innate - drug effects | Toll-Like Receptor 4 - drug effects | Mice, Inbred C57BL | Pancreas - drug effects | Chemical and Drug Induced Liver Injury - genetics | Pancreatitis - chemically induced | Animals | Carrier Proteins - metabolism | beta-Arrestin 2 | Inflammasomes - immunology | Macrophages - drug effects | Pancreatitis - pathology | Pancreatitis - metabolism | Ceruletide | Lactates | Gastrointestinal diseases | Inflammation | Index Medicus | Abridged Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2013, Volume 8, Issue 1, pp. e53745 - e53745
Background: Ipilimumab, a cytotoxic T-lymphocyte antigen-4 (CTLA-4) blocking antibody, has been approved for the treatment of metastatic melanoma and induces... 
TRIAL | CTLA-4 BLOCKADE | INDUCED SARCOIDOSIS | LYMPHOCYTE-ASSOCIATED ANTIGEN-4 | AUTOIMMUNE-DISEASES | PHASE-I/II | MULTIDISCIPLINARY SCIENCES | TREMELIMUMAB CP-675,206 | MONOCLONAL-ANTIBODY | PATIENT | CANCER | Skin Neoplasms - drug therapy | Humans | Ipilimumab | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Neoplasm Metastasis | Liver - drug effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Endocrine System - drug effects | Adult | Female | Retrospective Studies | Antibodies, Monoclonal - immunology | Kidney - drug effects | Antineoplastic Agents - immunology | Pancreas - drug effects | Gastrointestinal Tract - drug effects | Melanoma - pathology | CTLA-4 Antigen - immunology | Nervous System - drug effects | Melanoma - drug therapy | Respiratory System - drug effects | Aged | Skin - drug effects | Antimitotic agents | Antigens | Care and treatment | Algorithms | Lymphocytes | Melanoma | Skin | Metastasis | Antineoplastic agents | Skin cancer | Cancer | Aseptic meningitis | Guillain-Barre syndrome | Exanthema | Central nervous system | Blocking antibodies | Cytotoxicity | Oncology | Lymphocytes T | Metastases | CTLA-4 protein | Intestine | Gastroenterology | Meningitis | Internal medicine | Hematology | Sarcoidosis | Dermatology | Management | Regression analysis | Patients | Eosinophilia | Morbidity | Inflammatory bowel disease | Pathology | Side effects | Hospitals | Perforations | Medical prognosis | Antitumor activity | Autoimmune diseases | Endocrinology | Index Medicus
Journal Article
Diabetologia, ISSN 0012-186X, 11/1997, Volume 40, Issue 11, pp. 1269 - 1277
Neuropeptide Y in the hypothalamus is a potent physiological stimulator of feeding, and may contribute to the characteristic metabolic defects of obesity when... 
hypothalamo-pituitary adrenal axis | proinsulin | vagus nerve | glucose utilisation | Medicine & Public Health | Human Physiology | Intracerebroventricular | insulin | Metabolic Diseases | neuropeptide Y | Internal Medicine | NERVOUS-SYSTEM | ACID | INVOLVEMENT | ENERGY-BALANCE | CUSHINGS-SYNDROME | OBESITY | CORTICOTROPIN-RELEASING FACTOR | INSULIN-RESISTANCE | ENDOCRINOLOGY & METABOLISM | intracerebroventricular | BETA-CELL | ADIPOSE-TISSUE | Injections, Intraventricular | Body Weight - drug effects | Neuropeptide Y - administration & dosage | Muscle, Skeletal - metabolism | Chromatography, High Pressure Liquid | Insulin - blood | Corticotropin-Releasing Hormone - analysis | Adipose Tissue - metabolism | Time Factors | Radioimmunoassay | Female | Corticosterone - blood | Hypothalamus - drug effects | Adrenocorticotropic Hormone - blood | Pituitary-Adrenal System - physiology | Pituitary-Adrenal System - drug effects | Hypothalamus - physiology | Rats | Glucose - pharmacology | Rats, Sprague-Dawley | Vagotomy | Eating - drug effects | Vagus Nerve - physiology | Organ Size - drug effects | Animals | Pancreas - anatomy & histology | Glucose - metabolism | Neuropeptide Y | Corticotropin releasing hormone | Glucose metabolism | Corticosterone | Physiological aspects | ACTH | Insulin resistance | Universities and colleges | Glucose | Dextrose | Index Medicus
Journal Article
American Journal of Physiology - Endocrinology and Metabolism, ISSN 0193-1849, 03/2014, Volume 306, Issue 6, pp. E627 - E634
The experimental protocol of the perfused rat pancreas is commonly used to evaluate beta-cell function. In this context, mathematical models become useful... 
β-cell function | Biphasic insulin secretion | Minimal model | Lixisenatide | Perfused pancreas | PHYSIOLOGY | HIGH-FAT DIET | SENSITIVITY | DIABETIC-RATS | RELEASE | TAK-875 | GRANULES | biphasic insulin secretion | beta-cell function | perfused pancreas | lixisenatide | GLUCOSE | ENDOCRINOLOGY & METABOLISM | DYNAMICS | minimal model | GLUCAGON | Receptors, G-Protein-Coupled - metabolism | Hypoglycemic Agents - metabolism | Male | Receptors, G-Protein-Coupled - agonists | Insulin-Secreting Cells - metabolism | Glucagon-Like Peptide 1 - agonists | Monomeric GTP-Binding Proteins - pharmacology | Insulin Secretion | Receptors, Glucagon - agonists | Reproducibility of Results | Glucagon-Like Peptide 1 - metabolism | Hypoglycemic Agents - agonists | Glucagon-Like Peptide 1 - pharmacology | Pancreas - drug effects | Rats | Receptors, Glucagon - metabolism | Pancreas - metabolism | Rats, Sprague-Dawley | Hypoglycemic Agents - pharmacology | Peptides - pharmacology | Insulin - metabolism | Algorithms | Animals | Glucagon-Like Peptide-1 Receptor | Insulin-Secreting Cells - drug effects | Monomeric GTP-Binding Proteins - metabolism | Signal Transduction - drug effects | Models, Biological | Perfusion | Glucose - metabolism | Kinetics | In Vitro Techniques | Physiological aspects | Pancreas | Glucose tolerance tests | Insulin | Methods | Rodents | Index Medicus
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2010, Volume 56, Issue 25, pp. 2115 - 2125
Objectives In this study, we have investigated the effects of cannabidiol (CBD) on myocardial dysfunction, inflammation, oxidative/nitrative stress, cell... 
Cardiovascular | Internal Medicine | diabetic complications | cannabinoids | inflammation | oxidative stress | CONSTITUENT | CARDIAC & CARDIOVASCULAR SYSTEMS | METALLOTHIONEIN | MITOCHONDRIAL | ENDOCANNABINOID SYSTEM | ANTAGONISM | PROTECTS | INHIBITION | DISEASE | NF-KAPPA-B | Diabetic Cardiomyopathies - metabolism | Reactive Oxygen Species - metabolism | Diabetic Cardiomyopathies - drug therapy | Apoptosis - drug effects | Humans | Body Weight - drug effects | Male | NF-kappa B - metabolism | Glucose | Cannabidiol - therapeutic use | Drug Evaluation, Preclinical | Disease Models, Animal | Mice, Inbred C57BL | Cells, Cultured | Pancreas - drug effects | Cannabidiol - pharmacology | Myocardium - pathology | Pancreas - metabolism | Blood Glucose - drug effects | Insulin - metabolism | Animals | MAP Kinase Signaling System - drug effects | Myocytes, Cardiac - drug effects | Fibrosis | Diabetic Cardiomyopathies - pathology | Hemodynamics - drug effects | Mice | Oxidative Stress - drug effects | Phosphates | Oxidative stress | Medical colleges | Niacinamide | Cardiomyopathy | Alcoholism | Radiation | Superoxide | Biochemistry | Dextrose | Purines | Cannabinoids | Cell death | Analysis | Nitric oxide | Protein kinases | Heart diseases | Adenosine triphosphatase | Jewish schools | Mortality | Cardiovascular disease | Cardiomyocytes | Kinases | Experiments | Variance analysis | Antioxidants | Proteins | Polymerase chain reaction | Rodents | Atherosclerosis | Diabetes | Pancreas | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article
Cell Stem Cell, ISSN 1934-5909, 02/2014, Volume 14, Issue 2, pp. 237 - 252
Journal Article
RNA, ISSN 1355-8382, 2012, Volume 18, Issue 7, pp. 1373 - 1384
The recruitment of ribosomes to eukaryotic cellular mRNAs requires the activity of two prototypic RNA helicases, eukaryotic initiation factor (eIF) 4AI and... 
Translation | eIF4AI | eIF4AII | DEAD-box RNA helicase | Hippuristanol | Translational control | RNA helicase | MAMMALIAN TRANSLATION | FACTOR EIF-4A | BIOCHEMISTRY & MOLECULAR BIOLOGY | BINDING-PROTEIN | CROSS-LINKING | translational control | 5' END | EUKARYOTIC TRANSLATION INITIATION | MESSENGER-RNA | translation | hippuristanol | DEGRADATION | INHIBITS TRANSLATION | RNA HELICASE EIF4A | Transcription, Genetic - drug effects | Testis - metabolism | Humans | Fetus - metabolism | Male | Muscle, Skeletal - metabolism | Spleen - drug effects | Prostate - metabolism | Testis - drug effects | Brain - metabolism | Kidney - metabolism | Protein Isoforms - metabolism | Liver - drug effects | Muscle, Skeletal - drug effects | Myocardium - metabolism | Prostate - drug effects | Adult | Female | Ovary - drug effects | Lung - metabolism | Thymus Gland - metabolism | Ovary - metabolism | Sterols - pharmacology | Cell Line | Kidney - drug effects | Liver - metabolism | Pancreas - drug effects | Pancreas - metabolism | Thymus Gland - drug effects | Eukaryotic Initiation Factor-4A - antagonists & inhibitors | Brain - drug effects | Fetus - drug effects | Placenta - drug effects | Placenta - metabolism | Pregnancy | Transcription, Genetic - physiology | Spleen - metabolism | Lung - drug effects | Eukaryotic Initiation Factor-4A - metabolism | Index Medicus
Journal Article
Molecular and Cellular Biology, ISSN 0270-7306, 10/2008, Volume 28, Issue 20, pp. 6373 - 6383
Journal Article
Journal Article
Diabetes, ISSN 0012-1797, 11/2011, Volume 60, Issue 11, pp. 2872 - 2882
OBJECTIVE-To evaluate whether healthy or diabetic adult mice can tolerate an extreme loss of pancreatic a-cells and how this sudden massive depletion affects... 
INSULIN | HYPERGLUCAGONEMIA | ENDOCRINE PANCREAS | GLUCOSE-HOMEOSTASIS | ENDOCRINOLOGY & METABOLISM | RECEPTOR GENE | SECRETION | DIFFERENTIATION | HYPERPLASIA | ISLET CELLS | EXPRESSION | Insulin-Secreting Cells - secretion | Apoptosis - drug effects | Cell Count | Glucagon - genetics | Male | Diphtheria Toxin - toxicity | Insulin - blood | Glucagon - blood | Diabetes Mellitus, Experimental - blood | Hypoglycemia - prevention & control | Intercellular Signaling Peptides and Proteins - metabolism | Glucagon-Secreting Cells - drug effects | Insulin-Secreting Cells - metabolism | Hyperglycemia - chemically induced | Glucagon-Secreting Cells - metabolism | Diabetes Mellitus, Experimental - chemically induced | Diabetes Mellitus, Experimental - metabolism | Glucagon-Secreting Cells - secretion | Hyperglycemia - prevention & control | Promoter Regions, Genetic | Signal Transduction | Glucagon-Secreting Cells - pathology | Intercellular Signaling Peptides and Proteins - genetics | Pancreas - drug effects | Pancreas - pathology | Receptors, Glucagon - metabolism | Mice, Transgenic | Pancreas - metabolism | Heparin-binding EGF-like Growth Factor | Insulin - metabolism | Animals | Insulin-Secreting Cells - drug effects | Tamoxifen - pharmacology | Diabetes Mellitus, Experimental - pathology | Glucagon - metabolism | Mice | Streptozocin - toxicity | Insulin-Secreting Cells - pathology | Selective Estrogen Receptor Modulators - pharmacology | Index Medicus | Abridged Index Medicus | Islet Studies
Journal Article
Nature Medicine, ISSN 1078-8956, 11/2015, Volume 21, Issue 11, pp. 1364 - 1371
Journal Article